Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Malignant Neoplasm
75%
Geriatric Oncology
60%
Geriatric Assessment
36%
Diseases
31%
Overall Survival
28%
Progression Free Survival
25%
Chemotherapy
25%
Immunotherapy
22%
Arm
22%
Clinical Trial
21%
Neoadjuvant Therapy
20%
Combination Therapy
20%
Cabozantinib
20%
Pelareorep
20%
Abdominal Cancer
20%
Pancreas Adenocarcinoma
20%
Colorectal Carcinoma
20%
Sorafenib
18%
Atezolizumab
17%
Bevacizumab
17%
Oncology
17%
Next Generation Sequencing
16%
Neoplasm
15%
Nivolumab
14%
Liver Cirrhosis
13%
Supportive Care
12%
Transcatheter Arterial Chemoembolization
12%
Gemcitabine
11%
Immunohistochemistry
11%
Tumor
10%
Microsatellite Instability
10%
Randomized Controlled Trial
10%
Regorafenib
10%
Immune Checkpoint Inhibitor
10%
Mipsagargin
10%
Distant Metastasis
10%
Veterans Health
10%
Rectum Cancer
10%
Medical Oncology
10%
Liver Transplantation
10%
Meta-Analysis
10%
External Beam Radiotherapy
10%
Peritoneum Metastasis
10%
Intraperitoneal Chemotherapy
10%
Clinical Assessment
10%
Metastatic Colorectal Cancer
10%
Adenocarcinoma
10%
Hereditary Nonpolyposis Colorectal Cancer
10%
Oncolytic Virus
10%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
70%
Immunotherapy
35%
Diseases
29%
Overall Survival
23%
Combination Therapy
20%
Solid Malignant Neoplasm
20%
Sorafenib
20%
Progression Free Survival
18%
Atezolizumab
17%
Bevacizumab
17%
Neoplasm
16%
Protein Tyrosine Kinase Inhibitor
15%
Adverse Event
12%
Chemotherapy Regimens
12%
Pharmacodynamics
11%
Pharmacokinetics
10%
Phase I Trials
10%
STAT3 Protein
10%
Gemcitabine
10%
Colorectal Carcinoma
10%
Mipsagargin
10%
Off-Label Use
10%
Metastatic Colorectal Cancer
10%
Pancreas Adenocarcinoma
10%
Pelareorep
10%
Regorafenib
10%
Hydroxychloroquine
10%
Vorinostat
10%
Immune Checkpoint Inhibitor
10%
Malignant Neoplasm
8%
Antitumor Activity
6%
Lenvatinib
6%
Survival Rate
6%
Cytotoxicity
5%
Abdominal Cancer
5%
Monotherapy
5%
Ovary Cancer
5%
Transcription Factors
5%
Diarrhea
5%
Advanced Cancer
5%
Nursing and Health Professions
Liver Cell Carcinoma
40%
Clinical Outcome
22%
Immunotherapy
20%
Combination Therapy
20%
Cancer Center
13%
Confidence Interval
12%
Overall Survival
12%
Diseases
12%
Gerontology
11%
Geriatric Assessment
10%
Neoadjuvant Therapy
10%
External Beam Radiotherapy
10%
Rectum Cancer
10%
Adenocarcinoma
10%
Abdominal Cancer
10%
Malignant Neoplasm
10%
Meta Analysis
10%
Activity Tracker
10%
Chemoembolization
10%
Organ Preservation
10%
Bevacizumab
10%
Atezolizumab
10%
Safety Net Hospital
10%
Progression Free Survival
8%
Hazard Ratio
5%
Protein Tyrosine Kinase Inhibitor
5%
Patient Population
5%
Nuclear Magnetic Resonance Imaging
5%
Clinical Practice
5%
